C D Johnson

Persistent organ failure during the first week as a marker of fatal outcome in acute pancreatitis

C D Johnson · Gut · 2004 · 646 citations · Full text

Double blind, randomised, placebo controlled study of a platelet activating factor antagonist, lexipafant, in the treatment and prevention of organ failure in predicted severe acute pancreatitis

C D Johnson · Gut · 2001 · 340 citations · Full text

Development of a disease specific quality of life (QoL) questionnaire module to supplement the EORTC core cancer QoL questionnaire, the QLQ-C30 in patients with pancreatic cancer

Deborah Fitzsimmons, C D Johnson, S. George et al. · European Journal of Cancer · 1999 · 263 citations

Quality Of Life, Life Assessment, Pancreatic Cancer +10

A randomised clinical trial to assess the effect of total enteral and total parenteral nutritional support on metabolic, inflammatory and oxidative markers in patients with predicted severe acute pancreatitis (APACHEE II ≥ 6)

Rajesh Gupta, Krutika Patel, Philip C. Calder et al. · Pancreatology · 2003 · 251 citations

Inflammation, Nutrition, Metabolic Syndrome +10

Development of an EORTC disease-specific quality of life module for use in patients with gastric cancer

C W Vickery, Jane Blazeby, Thierry Conroy et al. · European Journal of Cancer · 2001 · 195 citations

Eortc Disease-specific Quality, Life Module, Oncology +7